1. Home
  2. RPID vs WIA Comparison

RPID vs WIA Comparison

Compare RPID & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • WIA
  • Stock Information
  • Founded
  • RPID 2006
  • WIA 2003
  • Country
  • RPID United States
  • WIA United States
  • Employees
  • RPID 163
  • WIA N/A
  • Industry
  • RPID Medical Specialities
  • WIA Trusts Except Educational Religious and Charitable
  • Sector
  • RPID Health Care
  • WIA Finance
  • Exchange
  • RPID Nasdaq
  • WIA Nasdaq
  • Market Cap
  • RPID 183.5M
  • WIA 197.8M
  • IPO Year
  • RPID 2021
  • WIA N/A
  • Fundamental
  • Price
  • RPID $4.13
  • WIA $8.35
  • Analyst Decision
  • RPID Strong Buy
  • WIA
  • Analyst Count
  • RPID 2
  • WIA 0
  • Target Price
  • RPID $8.00
  • WIA N/A
  • AVG Volume (30 Days)
  • RPID 128.7K
  • WIA 39.2K
  • Earning Date
  • RPID 11-07-2025
  • WIA 01-01-0001
  • Dividend Yield
  • RPID N/A
  • WIA 12.29%
  • EPS Growth
  • RPID N/A
  • WIA N/A
  • EPS
  • RPID N/A
  • WIA N/A
  • Revenue
  • RPID $30,523,000.00
  • WIA N/A
  • Revenue This Year
  • RPID $16.63
  • WIA N/A
  • Revenue Next Year
  • RPID $21.98
  • WIA N/A
  • P/E Ratio
  • RPID N/A
  • WIA N/A
  • Revenue Growth
  • RPID 16.63
  • WIA N/A
  • 52 Week Low
  • RPID $0.87
  • WIA $7.56
  • 52 Week High
  • RPID $4.50
  • WIA $8.91
  • Technical
  • Relative Strength Index (RSI)
  • RPID 62.21
  • WIA 50.08
  • Support Level
  • RPID $3.93
  • WIA $8.26
  • Resistance Level
  • RPID $4.29
  • WIA $8.37
  • Average True Range (ATR)
  • RPID 0.35
  • WIA 0.06
  • MACD
  • RPID 0.03
  • WIA -0.00
  • Stochastic Oscillator
  • RPID 80.85
  • WIA 39.29

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

Share on Social Networks: